0.7775

2.81% -0.0225

After Hours: .75 -0.0275 -3.54%

Predictive Oncology Inc (POAI)

Overview News Price History Financials Discussions Forecast Stock Split

Predictive Oncology Inc stock is traded at $0.7775, with a volume of 81,530. It is down -2.81% in the last 24 hours and down -7.00% over the past month. Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Previous Close:

$0.80

Open:

$0.786

24h Volume:

81,530

Relative Volume:

0.79

Market Cap:

$5.33M

Revenue:

$1.78M

Net Income/Loss:

$-13.98M

P/E Ratio:

-0.1606

EPS:

-4.84

Net Cash Flow:

$-13.49M

1W Performance:

+19.14%

1M Performance:

-7.00%

6M Performance:

-50.46%

1Y Performance:

-73.28%

1-Day Range:

$0.7746

$0.8254

1-Week Range:

$0.6565

$0.8548

52-Week Range:

$0.55

$3.76

Predictive Oncology Inc Stock (POAI) Company Profile

Name

Predictive Oncology Inc

Sector

Healthcare (1200)

Industry

Medical Instruments & Supplies (58)

Phone

412-432-1500

Address

91 43RD STREET, PITTSBURGH, MN

Employee

Twitter

Next Earnings Date

2024-11-12

Latest SEC Filings

POAI's Discussions on Twitter

Compare POAI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
POAI Predictive Oncology Inc	0.7775	5.33M	1.78M	-13.98M	-13.49M	-4.84
ISRG Intuitive Surgical Inc	538.55	192.83B	7.87B	2.24B	586.00M	4.25
BDX Becton Dickinson Co	221.98	64.77B	20.18B	1.73B	3.07B	5.51
ALC Alcon Inc	88.23	43.75B	9.76B	1.16B	665.00M	0.72
RMD Resmed Inc	249.33	36.84B	4.81B	1.11B	1.35B	6.16
WST West Pharmaceutical Services Inc	323.32	23.33B	2.88B	499.60M	321.60M	7.41

Predictive Oncology Inc Stock (POAI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-19-24	Initiated	H.C. Wainwright	Buy

Predictive Oncology Inc Stock (POAI) Latest News

Nov 25, 2024

Predictive Oncology faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com South Africa

Nov 25, 2024

Nov 24, 2024

Predictive Oncology faces Nasdaq delisting over equity shortfall - Investing.com India

Nov 24, 2024

Nov 23, 2024

Predictive Oncology Receives Notice of Non-Compliance from Nasdaq - Defense World

Nov 23, 2024

Nov 18, 2024

Predictive Oncology Inc. Issues Press Release Detailing Financial Results for Q3 2024Predictive Oncology Inc., a leading biopharmaceutical company, released a pivotal press release detailing its financial results for the quarter ending September 30 - Defense World

Nov 18, 2024

Nov 15, 2024

This SolarEdge Technologies Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga

Nov 15, 2024

Pre-market Movers: GANX, TFFP, AKYA, CLDI... - RTTNews

Nov 15, 2024

Predictive Oncology downgraded to Neutral from Buy at H.C. Wainwright - TipRanks

Nov 15, 2024

Predictive Oncology Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 15, 2024

Nov 13, 2024

Predictive Oncology Inc. Reports Q3 2024 Earnings - TipRanks

Nov 13, 2024

U.S. STOCKS BankUnited, Natera, Adaptimmune - XM

Nov 13, 2024

Artificial Intelligence in Drug Discovery Market Expecting Huge Demand in Upcoming Years - openPR

Nov 13, 2024

Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update - The Manila Times

Nov 13, 2024

Predictive Oncology Reports Q3 Loss, Launches Strategic Review Amid 49% Revenue Drop | POAI Stock News - StockTitan

Nov 13, 2024

Nov 12, 2024

Predictive Oncology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 06, 2024

International Conference on the Crystallization of Biological Macromolecules - Arizona State University (ASU)

Nov 06, 2024

Oct 30, 2024

American Well Corporation (AMWL) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Oct 30, 2024

Oct 28, 2024

Artificial Intelligence in Biotechnology Market to Hit USD 7.75 Billion by 2029 with 19.1% CAGR | MarketsandMarkets™ - PR Newswire UK

Oct 28, 2024

Some Major Key Players In The Genomic Cancer Panel and Profiling Market: - InsightAce Analytic

Oct 28, 2024

Oct 25, 2024

AngioDynamics (ANGO) Stock Dips Amidst Financial Performance Rev - GuruFocus.com

Oct 25, 2024

Oct 18, 2024

, a machine learning-based RNA oncology test predicting immunotherapy response - Business Wire

Oct 18, 2024

Oct 13, 2024

HC Wainwright & Co. Initiates Coverage of Predictive Oncology (POAI) with Buy Recommendation - MSN

Oct 13, 2024

Oct 11, 2024

Artificial Intelligence in Genomics Market is Estimated to Reach $5.5 Billion By 2032 - 대구포스트

Oct 11, 2024

Oct 09, 2024

POAI stock touches 52-week low at $0.64 amid market challenges By Investing.com - Investing.com South Africa

Oct 09, 2024